MY150480A - Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof - Google Patents
Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereofInfo
- Publication number
- MY150480A MY150480A MYPI20100364A MY150480A MY 150480 A MY150480 A MY 150480A MY PI20100364 A MYPI20100364 A MY PI20100364A MY 150480 A MY150480 A MY 150480A
- Authority
- MY
- Malaysia
- Prior art keywords
- preparation
- calcium channel
- channel antagonist
- pharmaceutical composition
- composition containing
- Prior art date
Links
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 title abstract 2
- 229940127291 Calcium channel antagonist Drugs 0.000 title abstract 2
- 239000000480 calcium channel blocker Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- 229910002012 Aerosil® Inorganic materials 0.000 abstract 1
- 229940075614 colloidal silicon dioxide Drugs 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- ZDXUKAKRHYTAKV-UHFFFAOYSA-N lercanidipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZDXUKAKRHYTAKV-UHFFFAOYSA-N 0.000 abstract 1
- 229960004294 lercanidipine Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007909 solid dosage form Substances 0.000 abstract 1
- 238000005550 wet granulation Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
THE PRESENT INVENTION RELATES TO THE FORMULATION OF SOLID DOSAGE FORMS COMPRISING A THERAPEUTICALLY EFFECTIVE AMOUNT OF A DIHYDROPYRIDINE CALCIUM CHANNEL ANTAGONIST SUCH AS LERCANIDIPINE OR SALT THEREOF, IN COMBINATION WITH COLLOIDAL SILICON DIOXIDE SUCH AS AEROSIL?? TO ENHANCE BIOAVAILABILITY AND IMPROVE SOLUBILITY, AND A PROCESS FOR THE PREPARATION THEREOF BY WET GRANULATION. (NO SUITABLE
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI20100364 MY150480A (en) | 2007-07-23 | 2007-07-23 | Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI20100364 MY150480A (en) | 2007-07-23 | 2007-07-23 | Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY150480A true MY150480A (en) | 2014-01-30 |
Family
ID=52595534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20100364 MY150480A (en) | 2007-07-23 | 2007-07-23 | Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof |
Country Status (1)
| Country | Link |
|---|---|
| MY (1) | MY150480A (en) |
-
2007
- 2007-07-23 MY MYPI20100364 patent/MY150480A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010000856A (en) | Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof. | |
| JO2973B1 (en) | Fumarate Salt Of (alphaS, betaR)-6-Bromo-alfa-[2-(dimethylamino)ethyl]-2- Methoxy-alpha-1-naphthalenyl-beta-phenyl-3- Quinolineethanol | |
| WO2010049449A3 (en) | Novel salts of sunitinib | |
| ZA201003380B (en) | Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and methhod for the preparation thereof | |
| WO2008001201A3 (en) | Pharmaceutical compositions of clopidogrel | |
| WO2010070677A3 (en) | A process for the preparation of prasugrel and its pharmaceutically acceptable salts thereof | |
| MX2009008463A (en) | Bioavailable formulations of heterocyclic compounds. | |
| NZ591204A (en) | Pharmaceutical compositions and methods for stabilizing the same | |
| EA200900463A1 (en) | ARIPIPRAZOLA HEMIFUMARAT AND METHOD FOR ITS OBTAINING | |
| WO2010044097A3 (en) | Novel dosage form of paliperidone and process for preparing the same | |
| WO2009084036A3 (en) | Composition for treatment of viral infections | |
| WO2009049648A3 (en) | Improved pharmaceutical composition containing antiviral agent and method for the preparation thereof | |
| GR1008821B (en) | Pharmaceutical composition comprising ivabradine hydrochloride and method for preparation thereof | |
| WO2010061220A3 (en) | Novel processes and pure polymorphs | |
| GR20070100405A (en) | Improved pharmaceutical composition containing acetylcholine esterace inhibitor and method for the preparation thereof | |
| WO2007110765A3 (en) | Processes for the preparation of octreotide | |
| MY150480A (en) | Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof | |
| HK1128462A1 (en) | Novel method for preparation of ammonium salts of esomeprazole | |
| HRP20090102T3 (en) | Improved pharmaceutical composition containing ace inhibitor and method for the preparation thereof | |
| WO2011086577A3 (en) | Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts | |
| WO2010061219A3 (en) | Polymorphs | |
| WO2007102171A3 (en) | Novel salts of 1h-1-benzazepine-1-acetic acid, their preparation and pharmaceutical composition | |
| WO2007052167A3 (en) | Stable composition for a pharmaceutical formulation containing olanzapine | |
| CO6260055A2 (en) | PHARMACEUTICAL COMPOSITION CONTAINING AN ANTIGONIST OF THE CALCIUM CHANNEL OF TYPE DIHYDROPIRIDINE AND METHOD FOR THE PREPARATION OF THE SAME | |
| GR1007741B (en) | Pharmaceutical composition containing an atypical antipsychotic agent and method for the preparation thereof |